Header Logo

Connection

Beverly Sha to Receptors, Tumor Necrosis Factor, Type II

Back to Details
This is a "connection" page, showing publications Beverly Sha has written about Receptors, Tumor Necrosis Factor, Type II.
Beverly Sha
Connection Strength
0.011
Receptors, Tumor Necrosis Factor, Type II
  1. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.